Related Experiment Video
Updated: Jul 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
On estimating medical cost and incremental cost-effectiveness ratios with censored data
1Department of Biostatistics, University of Rochester, New York 14642, USA. zhao@bst.rochester.edu
Abstract:
Medical cost estimation is very important to health care organizations and health policy makers. We consider cost-effectiveness analysis for competing treatments in a staggered-entry, survival-analysis-based clinical trial. We propose a method for estimating mean medical cost over patients in such settings. The proposed estimator is shown to be consistent and asymptotically normal, and its asymptotic variance can be obtained. In addition, we propose a method for estimating the incremental cost-effectiveness ratio and for obtaining a confidence interval for it. Simulation experiments are conducted to evaluate our proposed methods. Finally, we apply our methods to a clinical trial comparing the cost effectiveness of implanted cardiac defibrillators with conventional therapy for individuals at high risk for ventricular arrhythmias.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Kaplan-Meier Approach
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Censoring Survival Data

